JP2003511437A - N−[3−[[2−(3,4−ジメトキシフェニル)エチル]アミノ]プロピル]−4−ニトロベンズアミド塩酸塩の多型相 - Google Patents
N−[3−[[2−(3,4−ジメトキシフェニル)エチル]アミノ]プロピル]−4−ニトロベンズアミド塩酸塩の多型相Info
- Publication number
- JP2003511437A JP2003511437A JP2001530092A JP2001530092A JP2003511437A JP 2003511437 A JP2003511437 A JP 2003511437A JP 2001530092 A JP2001530092 A JP 2001530092A JP 2001530092 A JP2001530092 A JP 2001530092A JP 2003511437 A JP2003511437 A JP 2003511437A
- Authority
- JP
- Japan
- Prior art keywords
- polymorphic form
- propyl
- dimethoxyphenyl
- ethyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9923933.7 | 1999-10-08 | ||
GBGB9923933.7A GB9923933D0 (en) | 1999-10-08 | 1999-10-08 | Novel pharmaceutical |
PCT/GB2000/003847 WO2001027071A1 (en) | 1999-10-08 | 2000-10-06 | Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003511437A true JP2003511437A (ja) | 2003-03-25 |
Family
ID=10862442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001530092A Pending JP2003511437A (ja) | 1999-10-08 | 2000-10-06 | N−[3−[[2−(3,4−ジメトキシフェニル)エチル]アミノ]プロピル]−4−ニトロベンズアミド塩酸塩の多型相 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1218334A1 (no) |
JP (1) | JP2003511437A (no) |
KR (1) | KR20020043618A (no) |
CN (1) | CN1384817A (no) |
AU (1) | AU7546000A (no) |
BR (1) | BR0014591A (no) |
CA (1) | CA2386845A1 (no) |
CZ (1) | CZ20021189A3 (no) |
GB (1) | GB9923933D0 (no) |
HK (1) | HK1049147A1 (no) |
HU (1) | HUP0203582A2 (no) |
IL (1) | IL148966A0 (no) |
MX (1) | MXPA02003516A (no) |
NO (1) | NO20021639L (no) |
PL (1) | PL354137A1 (no) |
TR (1) | TR200200949T2 (no) |
WO (1) | WO2001027071A1 (no) |
ZA (1) | ZA200202679B (no) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511689A (ja) * | 2006-12-06 | 2010-04-15 | ファイザー・インク | (3S)−3−[N−(N’−(2−tert−ブチルフェニル)オキサミル)アラニニル]アミノ−5−(2’,3’,5’,6’−テトラフルオロフェノキシ)−4−オキソペンタン酸の結晶形態 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7227033B2 (en) | 2002-01-09 | 2007-06-05 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2726267B1 (fr) * | 1994-10-26 | 1998-01-02 | Smithkline Beecham Lab | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |
GB9706376D0 (en) * | 1997-03-27 | 1997-05-14 | Smithkline Beecham Plc | Novel pharmaceutical |
-
1999
- 1999-10-08 GB GBGB9923933.7A patent/GB9923933D0/en not_active Ceased
-
2000
- 2000-10-06 JP JP2001530092A patent/JP2003511437A/ja active Pending
- 2000-10-06 HU HU0203582A patent/HUP0203582A2/hu unknown
- 2000-10-06 IL IL14896600A patent/IL148966A0/xx unknown
- 2000-10-06 CN CN00813990A patent/CN1384817A/zh active Pending
- 2000-10-06 TR TR2002/00949T patent/TR200200949T2/xx unknown
- 2000-10-06 MX MXPA02003516A patent/MXPA02003516A/es unknown
- 2000-10-06 AU AU75460/00A patent/AU7546000A/en not_active Abandoned
- 2000-10-06 BR BR0014591-2A patent/BR0014591A/pt not_active Application Discontinuation
- 2000-10-06 CZ CZ20021189A patent/CZ20021189A3/cs unknown
- 2000-10-06 WO PCT/GB2000/003847 patent/WO2001027071A1/en active IP Right Grant
- 2000-10-06 CA CA002386845A patent/CA2386845A1/en not_active Abandoned
- 2000-10-06 KR KR1020027004451A patent/KR20020043618A/ko not_active Application Discontinuation
- 2000-10-06 EP EP00964535A patent/EP1218334A1/en not_active Withdrawn
- 2000-10-06 PL PL00354137A patent/PL354137A1/xx not_active Application Discontinuation
-
2002
- 2002-04-05 NO NO20021639A patent/NO20021639L/no not_active Application Discontinuation
- 2002-04-05 ZA ZA200202679A patent/ZA200202679B/en unknown
- 2002-12-27 HK HK02109370.9A patent/HK1049147A1/zh unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511689A (ja) * | 2006-12-06 | 2010-04-15 | ファイザー・インク | (3S)−3−[N−(N’−(2−tert−ブチルフェニル)オキサミル)アラニニル]アミノ−5−(2’,3’,5’,6’−テトラフルオロフェノキシ)−4−オキソペンタン酸の結晶形態 |
Also Published As
Publication number | Publication date |
---|---|
GB9923933D0 (en) | 1999-12-08 |
EP1218334A1 (en) | 2002-07-03 |
NO20021639L (no) | 2002-05-30 |
PL354137A1 (en) | 2003-12-29 |
WO2001027071A1 (en) | 2001-04-19 |
HK1049147A1 (zh) | 2003-05-02 |
NO20021639D0 (no) | 2002-04-05 |
AU7546000A (en) | 2001-04-23 |
BR0014591A (pt) | 2002-06-11 |
MXPA02003516A (es) | 2004-09-10 |
CA2386845A1 (en) | 2001-04-19 |
TR200200949T2 (tr) | 2002-08-21 |
IL148966A0 (en) | 2002-11-10 |
HUP0203582A2 (en) | 2004-03-01 |
ZA200202679B (en) | 2003-05-28 |
CN1384817A (zh) | 2002-12-11 |
KR20020043618A (ko) | 2002-06-10 |
CZ20021189A3 (cs) | 2002-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2229342T3 (es) | Sales de mesilato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona(=ziprasidona),su preparacion y uso como antagonista de dopamina d2. | |
CA2107223C (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
JPS636058B2 (no) | ||
ES2218146T3 (es) | Derivado de tiazolidinadiona y su uso como antidiabetico. | |
JP2002532470A (ja) | パロキセチンマレイン酸塩の製法 | |
US5834495A (en) | Crystalline xamoneline tartrate | |
JP2003511437A (ja) | N−[3−[[2−(3,4−ジメトキシフェニル)エチル]アミノ]プロピル]−4−ニトロベンズアミド塩酸塩の多型相 | |
JP2003511438A (ja) | 水和n−[3−[[2−(3,4−ジメトキシフェニル)エチル]アミノ]プロピル]−4−ニトロベンズアミド塩酸塩およびその医薬組成物中における使用 | |
JP2001518088A (ja) | 抗不整脈薬として有用なニトロベンズアミド | |
US20040122019A1 (en) | Benzoylguanidine salt and hydrates thereof | |
JP3787139B2 (ja) | 1,2−ジヒドロ−2−オキソ−1,8−ナフチリジン誘導体 | |
US6706732B1 (en) | Nasal preparation of guanidinoimino quinoline derivatives | |
JP3001975B2 (ja) | 結晶性チアガビン塩酸塩−水和物、その製造方法および用途 | |
JPH09504787A (ja) | 抗不整脈活性を有する複素環カルボキサミド誘導体 | |
JPH09500631A (ja) | 抗不整脈剤としてのアザリシクロオクタン誘導体 | |
US20030083524A1 (en) | Nitro-benzamide useful as anti-arrhythmic agent | |
CZ341899A3 (cs) | Nitrobenzamid vhodný jako antiarytmický přípravek |